Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov;28(11):1590-1593.
doi: 10.1016/j.jiac.2022.07.023. Epub 2022 Aug 8.

Viral load may impact the diagnostic performance of nasal swabs in nucleic acid amplification test and quantitative antigen test for SARS-CoV-2 detection

Yoshihiro Fujiya  1 , Yuki Sato  2 , Yuki Katayama  2 , Shinya Nirasawa  2 , Mikako Moriai  2 , Masachika Saeki  2 , Yuki Yakuwa  2 , Ikumi Kitayama  2 , Koichi Asanuma  2 , Koji Kuronuma  3 , Satoshi Takahashi  4
Affiliations

Viral load may impact the diagnostic performance of nasal swabs in nucleic acid amplification test and quantitative antigen test for SARS-CoV-2 detection

Yoshihiro Fujiya et al. J Infect Chemother. 2022 Nov.

Abstract

Introduction: Compared to nasopharyngeal swabs (NPS), there has been insufficient evaluation of the diagnostic performance of nasal swabs (NS) for the detection of severe acute respiratory coronavirus 2 (SARS-CoV-2) in the nucleic acid amplification test (NAAT) and quantitative SARS-CoV-2 antigen test (QAT).

Methods: We prospectively compared healthcare worker-collected and flocked NS within nine days after symptom onset to paired NPS to detect SARS-CoV-2 in NAAT and QAT on the fully automated Lumipulse system. The agreement between sample types was evaluated, and cycle threshold (Ct) values and antigen levels were used as surrogate viral load measures.

Results: Sixty sets of NPS and NS samples were collected from 40 patients with COVID-19. The overall agreements between NAAT and QAT samples were 76.7% and 65.0%, respectively. In NAAT, the Ct value of NS was significantly higher, 5.9, than that of NPS. Thirty-nine (95.1%) NS tested positive in 41 positive-paired NPS with Ct ≤ 30. The negative correlation was observed between antigen levels of NS in QAT and Ct values of NS in NAAT (r = -0.88). In QAT, the antigen level of NS was significantly lower than that of NPS. Thirty-six (90.0%) NS tested positive in 40 positive-paired NPS with antigen levels >100 pg/mL, which were collected significantly earlier than those with antigen levels ≤100 pg/mL.

Conclusions: In NAAT and QAT, NS had limited performance in detecting SARS-CoV-2 compared to NPS. However, NS may be helpful for patients with COVID-19 with high viral loads or those in the early stages of the illness.

Keywords: Nasal swabs; Nasopharyngeal swabs; Nucleic acid amplification test; Quantitative SARS-CoV-2 antigen test; SARS-CoV-2; Viral load.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest Satoshi Takahashi received speaker honoraria from MSD K.K. and research grants from Shino-Test Corporation and Abbott Japan Co., Ltd.

Figures

Fig. 1
Fig. 1
a. The difference of Ct values in paired NPS-NAAT between positive and negative NS-NAAT b. The difference of Ct values in positive NAAT between nasopharyngeal swabs and nasal swabs (n = 44) NAAT, nucleic acid amplification test NS-NAAT, nucleic acid amplification test using nasal swabs NPS-NAAT, nucleic acid amplification test using nasopharyngeal swabs * Mann–Whitney U test was performed. ** Paired t-test was performed.
Fig. 2
Fig. 2
a. Correlation between antigen levels of NS-QAT and Ct values of NS-NAAT (n = 45) b. The difference of antigen levels in paired NPS-QAT between positive and negative NS-QAT c. The difference in antigen levels in positive QAT between nasopharyngeal swabs and nasal swabs (n = 39) QAT, quantitative antigen test NS-QAT, quantitative antigen test using nasal swabs NPS-QAT, quantitative antigen test using nasopharyngeal swabs NS-NAAT, nucleic acid amplification test using nasal swabs * Mann–Whitney U test was performed.
See this image and copyright information in PMC

References

    1. World Health Organization Diagnostic testing for SARS-CoV-2 interim guidance 11 september 2020. https://www.who.int/publications/i/item/diagnostic-testing-for-sars-cov-...
    1. Péré H., Podglajen I., Wack M., Flamarion E., Mirault T., Goudot G., et al. Nasal swab sampling for SARS-CoV-2: a convenient alternative in times of nasopharyngeal swab shortage. J Clin Microbiol. 2020;58 doi: 10.1128/JCM.00721-20. 20. - DOI - PMC - PubMed
    1. Tu Y.-P., Jennings R., Hart B., Cangelosi G.A., Wood R.C., Wehber K., et al. Swabs collected by patients or health care workers for SARS-CoV-2 testing. N Engl J Med. 2020;383:494–496. doi: 10.1056/NEJMc2016321. - DOI - PMC - PubMed
    1. Hanson K.E., Barker A.P., Hillyard D.R., Gilmore N., Barrett J.W., Orlandi R.R., et al. Self-collected anterior nasal and saliva specimens versus healthcare worker-collected nasopharyngeal swabs for the molecular detection of SARS-CoV-2. J Clin Microbiol. 2020;58 doi: 10.1128/JCM.01824-20. 20. - DOI - PMC - PubMed
    1. Callahan C., Lee R., Lee G., Zulauf K.E., Kirby J.E., Arnaout R. Nasal-swab testing misses patients with low SARS-CoV-2 viral loads. medRxiv. 2020 doi: 10.1101/2020.06.12.20128736. - DOI